1932

Abstract

Mass spectrometry–based diagnostics has the potential to revolutionize molecular medicine. Using modern mass-spectrometer technologies, clinical tests can be developed that are practical, robust, accurate, and inexpensive. Serum proteomic pattern profiling couples mass spectrometry with adaptive artificial-intelligence–based bioinformatics, which can now be employed to detect pathological states reflected in the serum proteome. With this approach, rapid and cost-effective tests with exquisite clinical sensitivity and specificity are emerging. These tools may dramatically change how disease is detected, monitored, and managed.

Loading

Article metrics loading...

/content/journals/10.1146/annurev.med.55.091902.105237
2004-02-18
2024-06-17
Loading full text...

Full text loading...

/content/journals/10.1146/annurev.med.55.091902.105237
Loading
/content/journals/10.1146/annurev.med.55.091902.105237
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error